Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Retained Earnings (2022 - 2026)

HeartSciences filings provide 5 years of Retained Earnings readings, the most recent being -$82.5 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 11.44% to -$82.5 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$82.5 million, a 11.44% decrease, with the full-year FY2025 number at -$76.1 million, down 13.01% from a year prior.
  • Retained Earnings hit -$82.5 million in Q1 2026 for HeartSciences, down from -$80.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$54.4 million in Q2 2022 to a low of -$82.5 million in Q1 2026.
  • Median Retained Earnings over the past 5 years was -$66.4 million (2024), compared with a mean of -$67.4 million.
  • Biggest five-year swings in Retained Earnings: fell 10.51% in 2023 and later dropped 13.03% in 2025.
  • HeartSciences' Retained Earnings stood at -$57.8 million in 2022, then decreased by 10.51% to -$63.9 million in 2023, then fell by 11.94% to -$71.5 million in 2024, then fell by 12.63% to -$80.5 million in 2025, then fell by 2.44% to -$82.5 million in 2026.
  • The last three reported values for Retained Earnings were -$82.5 million (Q1 2026), -$80.5 million (Q4 2025), and -$78.2 million (Q3 2025) per Business Quant data.